PRF Technologies (PRFX) Change in Account Payables (2019 - 2024)
PRF Technologies (PRFX) recorded quarterly Change in Account Payables of -$761000.0 in Q2 2024, down 189.01% on a QoQ basis from $855000.0 in Q1 2024, and down 1327.42% year-over-year from $62000.0 in Q3 2023.
PRF Technologies (PRFX) Change in Account Payables (2019 - 2024) Analysis & Trends
PRF Technologies has disclosed Change in Account Payables across 6 years of filings, most recently posting -$761000.0 for Q2 2024.
- Quarterly Change in Account Payables fell 1327.42% year-over-year to -$761000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$30000.0 (down 105.41% YoY) and the FY2024 annual result came in at $91000.0, up 78.43% from the prior year.
- Change in Account Payables declined to -$761000.0 in Q2 2024, from $855000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $855000.0 in Q1 2024 and troughed at -$761000.0 in Q2 2024.
- A 5-year average of $66058.8 and a median of $62000.0 in 2020 frame the typical range for Change in Account Payables.
- Biggest YoY gain for Change in Account Payables was 656.64% in 2024; the steepest drop was 1327.42% in 2024.
- Tracing PRFX's Change in Account Payables over 5 years: stood at $172000.0 in 2020, then slipped by 1.16% to $170000.0 in 2021, then jumped by 178.82% to $474000.0 in 2022, then tumbled by 84.39% to $74000.0 in 2023, then tumbled by 1128.38% to -$761000.0 in 2024.
- Business Quant data shows PRFX's Change in Account Payables at -$761000.0 in Q2 2024, $855000.0 in Q1 2024, and $74000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -761,000.00 |
| Jun 30, 2024 | -761,000.00 |
| Mar 31, 2024 | 855,000.00 |
| Mar 31, 2024 | 855,000.00 |
| Dec 31, 2023 | 74,000.00 |
| Dec 31, 2023 | 74,000.00 |
| Sep 30, 2023 | -198,000.00 |
| Sep 30, 2023 | -198,000.00 |
| Jun 30, 2023 | 62,000.00 |
| Jun 30, 2023 | 62,000.00 |
| Mar 31, 2023 | 113,000.00 |
| Mar 31, 2023 | 113,000.00 |
| Sep 30, 2022 | 474,000.00 |
| Sep 30, 2022 | 474,000.00 |
| Jun 30, 2022 | -94,000.00 |
| Jun 30, 2022 | -94,000.00 |
| Mar 31, 2022 | -186,000.00 |
| Mar 31, 2022 | -186,000.00 |
| Dec 31, 2021 | 170,000.00 |
| Dec 31, 2021 | 170,000.00 |